Vancomycin Hydrochloride Injection — FDA Drug Shortage

No longer listed by FDA — Hospira, Inc., A Pfizer Company

The FDA lists a drug shortage record for Vancomycin Hydrochloride Injection (injection) from Hospira, Inc., A Pfizer Company with status No longer listed by FDA. The shortage was first posted on Sep 9, 2025.

Shortage details

Status
No longer listed by FDA
Company
Hospira, Inc., A Pfizer Company
Package NDC
0409-6531-01
Dosage Form
Injection
Presentation
Vancomycin Hydrochloride, Injection, 750 mg Single Dose ADD-Vantage® Glass Vial (NDC 0409-6531-01)
Initial Posting
Sep 9, 2025

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.